The B-cell specific transcription factor, Oct-2, promotes Epstein-Barr virus latency by inhibiting the viral immediate-early protein, BZLF1.
The Epstein-Barr virus (EBV) latent-lytic switch is mediated by the BZLF1 immediate-early protein. EBV is normally latent in memory B cells, but cellular factors which promote viral latency specifically in B cells have not been identified. In this report, we demonstrate that the B-cell specific tran...
Main Authors: | Amanda R Robinson, Swee Sen Kwek, Shannon C Kenney |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-02-01
|
Series: | PLoS Pathogens |
Online Access: | http://europepmc.org/articles/PMC3276558?pdf=render |
Similar Items
-
MCAF1 and Rta-activated BZLF1 transcription in Epstein-Barr virus.
by: Ting-Yu Lin, et al.
Published: (2014-01-01) -
Design of Peptide Inhibitors That Bind the bZIP Domain of Epstein–Barr Virus Protein BZLF1
by: Chen, T. Scott, et al.
Published: (2015) -
BZLF1 governs CpG-methylated chromatin of Epstein-Barr Virus reversing epigenetic repression.
by: Anne Woellmer, et al.
Published: (2012-09-01) -
Rta is the principal activator of Epstein-Barr virus epithelial lytic transcription.
by: Ahmed Ali, et al.
Published: (2022-09-01) -
ΔNp63α promotes Epstein-Barr virus latency in undifferentiated epithelial cells.
by: Nicholas Van Sciver, et al.
Published: (2021-11-01)